Sevcik J - Search Results

1

Dipeptidyl peptidase-IV activity and/or structure homologs (DASH): contributing factors in the pathogenesis of rheumatic diseases?

Balaziova E, Sedova L, Mares V, Vlasicova K, Sevcik J, Sedo A. Balaziova E, et al. Among authors: sevcik j. Adv Exp Med Biol. 2006;575:169-74. doi: 10.1007/0-387-32824-6_18. Adv Exp Med Biol. 2006. PMID: 16700520 No abstract available.

2

Dipeptidyl peptidase-IV activity and/or structure homologues (DASH) in transformed neuroectodermal cells.

Malík R, Busek P, Mares V, Sevcík J, Kleibl Z, Sedo A. Malík R, et al. Among authors: sevcik j. Adv Exp Med Biol. 2003;524:95-102. doi: 10.1007/0-306-47920-6_12. Adv Exp Med Biol. 2003. PMID: 12683342 No abstract available.

3

Expression and function of dipeptidyl peptidase IV and related enzymes in cancer.

Busek P, Krepela E, Mares V, Vlasicova K, Sevcik J, Sedo A. Busek P, et al. Among authors: sevcik j. Adv Exp Med Biol. 2006;575:55-62. doi: 10.1007/0-387-32824-6_6. Adv Exp Med Biol. 2006. PMID: 16700508 No abstract available.

4

Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint.

Kleiblova P, Shaltiel IA, Benada J, Ševčík J, Pecháčková S, Pohlreich P, Voest EE, Dundr P, Bartek J, Kleibl Z, Medema RH, Macurek L. Kleiblova P, et al. Among authors: sevcik j. J Cell Biol. 2013 May 13;201(4):511-21. doi: 10.1083/jcb.201210031. Epub 2013 May 6. J Cell Biol. 2013. PMID: 23649806 Free PMC article.

5

RNA regulation and cancer development.

Scholzová E, Malík R, Sevcík J, Kleibl Z. Scholzová E, et al. Among authors: sevcik j. Cancer Lett. 2007 Feb 8;246(1-2):12-23. doi: 10.1016/j.canlet.2006.03.021. Epub 2006 May 3. Cancer Lett. 2007. PMID: 16675105 Review.

6

Long-term BRCA1 down-regulation by small hairpin RNAs targeting the 3' untranslated region.

Vondruskova E, Malik R, Sevcik J, Kleiblova P, Kleibl Z. Vondruskova E, et al. Among authors: sevcik j. Neoplasma. 2008;55(2):130-7. Neoplasma. 2008. PMID: 18237251

7

The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.

Kleibl Z, Havranek O, Hlavata I, Novotny J, Sevcik J, Pohlreich P, Soucek P. Kleibl Z, et al. Among authors: sevcik j. Eur J Cancer. 2009 Mar;45(4):618-24. doi: 10.1016/j.ejca.2008.09.022. Epub 2008 Nov 6. Eur J Cancer. 2009. PMID: 18996005

8

Multiplex PCR and NGS-based identification of mRNA splicing variants: Analysis of BRCA1 splicing pattern as a model.

Hojny J, Zemankova P, Lhota F, Sevcik J, Stranecky V, Hartmannova H, Hodanova K, Mestak O, Pavlista D, Janatova M, Soukupova J, Vocka M, Kleibl Z, Kleiblova P. Hojny J, et al. Among authors: sevcik j. Gene. 2017 Dec 30;637:41-49. doi: 10.1016/j.gene.2017.09.025. Epub 2017 Sep 14. Gene. 2017. PMID: 28919163

9

Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy.

Kleibl Z, Fidlerova J, Kleiblova P, Kormunda S, Bilek M, Bouskova K, Sevcik J, Novotny J. Kleibl Z, et al. Among authors: sevcik j. Neoplasma. 2009;56(4):303-16. doi: 10.4149/neo_2009_04_303. Neoplasma. 2009. PMID: 19473056

10

The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells.

Sevcik J, Falk M, Kleiblova P, Lhota F, Stefancikova L, Janatova M, Weiterova L, Lukasova E, Kozubek S, Pohlreich P, Kleibl Z. Sevcik J, et al. Cell Signal. 2012 May;24(5):1023-30. doi: 10.1016/j.cellsig.2011.12.023. Epub 2012 Jan 3. Cell Signal. 2012. PMID: 22245140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page